Furthermore, numerous studies have shown that MAGED2 is a tumor-specific antigen that plays an important role in tumor progression and metastasis, including hepatocellular carcinoma [16], gastric cancer [17], and lymphoma [18]. Here, MAGED2 is linked to gastric cancer.